ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102627 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102627; 2) Community: the network communities that were significantly associated with the response to NSC 102627; 3) Molecule: the relationships between components within communities and NSC 102627; 4) MDR: the compounds that were significantly associated with the NSC 102627.

NSC Compound Enrichment Correlation
NSC 760183 tert-butyl 2-((6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate 0.00671035899671664 0.10941012
NSC 86368 Null 0.00671035899671664 0.21509692
NSC 287459 Cytarabine AY 0.00705866970012644 0.62544338
NSC 287513 Ametantrone acetate 0.00705866970012644 0.46116802
NSC 35580 Null 0.00705866970012644 0.30536107
NSC 626164 Discorhabdin C-phenol . TFA 0.00705866970012644 0.32046646
NSC 695588 6-Amino-3-chloromethyl-1-[(5-methoxyindole-2-yl)-sufonyl] indoline 0.00705866970012644 0.22733466
NSC 724037 Null 0.00705866970012644 0.25465657
NSC 728856 5,6-Dihydro-6-[3-(3-imidazolylpropyl)amino-1-propyl]-5,11-di oxo-11H-indeno[1,2-c]isoquinoline dihdrochloride 0.00705866970012644 0.49719833
NSC 731104 Null 0.00705866970012644 0.34324982
Total:122  Current:27    [First] [Prev] [Next] [Last]